These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8729766)

  • 1. [Abnormalities of pattern reversal evoked visual potential in patients with defined multiple sclerosis].
    Tumas V; Sakamoto AC
    Arq Neuropsiquiatr; 1995 Dec; 53(4):743-8. PubMed ID: 8729766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pattern-reversal visual evoked potential abnormalities in patients with defined multiple sclerosis].
    Andrade EP; Sacai PY; Berezovsky A; Salomão SR
    Arq Bras Oftalmol; 2007; 70(6):943-8. PubMed ID: 18235904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
    Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
    Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hidden visual loss in multiple sclerosis. A comparison of pattern-reversal visual evoked potentials and contrast sensitivity.
    Leys MJ; Candaele CM; De Rouck AF; Odom JV
    Doc Ophthalmol; 1991; 77(3):255-64. PubMed ID: 1760973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 20/20 eye in multiple sclerosis.
    Kupersmith MJ; Nelson JI; Seiple WH; Carr RE; Weiss PA
    Neurology; 1983 Aug; 33(8):1015-20. PubMed ID: 6683795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a stenopeic semiocclusor enhances vep diagnosis.
    Garcia H; Barroso F; Mostajo ME; Balej J
    Electromyogr Clin Neurophysiol; 2004; 44(5):277-80. PubMed ID: 15378866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hyperventilation on pattern-reversal visual evoked potentials in patients with demyelination.
    Davies HD; Carroll WM; Mastaglia FL
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1392-6. PubMed ID: 3806116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual evoked potentials by different check sizes in patients with multiple sclerosis.
    Oishi M; Yamada T; Dickins QS; Kimura J
    Neurology; 1985 Oct; 35(10):1461-5. PubMed ID: 4033927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual function in multiple sclerosis.
    Ashworth B; Aspinall PA; Mitchell JD
    Doc Ophthalmol; 1989 Nov; 73(3):209-24. PubMed ID: 2638240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual evoked potentials and the visuogram in multiple sclerosis.
    Bodis-Wollner I; Hendley CD; Mylin LH; Thornton J
    Ann Neurol; 1979 Jan; 5(1):40-7. PubMed ID: 426467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N70 and P100 can be independently affected in multiple sclerosis.
    Ghilardi MF; Sartucci F; Brannan JR; Onofrj MC; Bodis-Wollner I; Mylin L; Stroch R
    Electroencephalogr Clin Neurophysiol; 1991; 80(1):1-7. PubMed ID: 1703943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked potentials in diagnosis of visual dysfunction in amateur boxers.
    Lesiakowski P; Lubiński W; Zwierko T
    Phys Sportsmed; 2018 Nov; 46(4):449-459. PubMed ID: 29973091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological examinations of the visual system in multiple sclerosis.
    Feinsod M; Abramsky O; Auerbach E
    J Neurol Sci; 1973 Oct; 20(2):161-75. PubMed ID: 4750875
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.
    Weinstock-Guttman B; Baier M; Stockton R; Weinstock A; Justinger T; Munschauer F; Brownscheidle C; Williams J; Fisher E; Miller D; Rudick R
    Mult Scler; 2003 Oct; 9(5):529-34. PubMed ID: 14582782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern-reversal visual evoked potentials as a diagnostic tool for ocular malingering.
    Soares TS; Sacai PY; Berezovsky A; Rocha DM; Watanabe SE; Salomão SR
    Arq Bras Oftalmol; 2016; 79(5):303-307. PubMed ID: 27982208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients.
    Carroll WM; Kriss A; Baraitser M; Barrett G; Halliday AM
    Brain; 1980 Jun; 103(2):413-34. PubMed ID: 7397485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.